Application of GOLD 2023 Initial Inhalation Therapy Recommendations in COPD patients: a real-world adherence and prognosis analysis
In the real world, many patients with COPD do not receive the initial inhalation therapy recommended by the GOLD 2023 report. However, adherence to the GOLD 2023 report may decrease the risk of future exacerbation. It implied that improved the dissemination and uptake of GOLD 2023 recommendations is needed in the clinical practice.
Authors
- Yuqin Zeng (ORCID: https://orcid.org/0000-0001-6599-3486)
- Dan Peng (ORCID: https://orcid.org/0000-0001-7419-5929)
- Si Lei (ORCID: https://orcid.org/0000-0002-9999-1726)
- Cong Liu (ORCID: https://orcid.org/0000-0003-3425-6672)
- Ping Chen (ORCID: https://orcid.org/0000-0001-8036-0855)
- Ping Zhang (ORCID: https://orcid.org/0000-0001-9163-6191)
- Tao Li (ORCID: https://orcid.org/0000-0002-2548-5476)
- Ling Lin (ORCID: https://orcid.org/0000-0003-4816-1834)
- Qing Song (ORCID: https://orcid.org/0000-0002-9773-1517)
- Dingding Deng
Institutions
- Central South University (CN)
- Changsha Medical University (CN)
- Shaoyang University (CN)
- Jiangxi Provincial People's Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Journal of Global Health
- Published
- 2025-11-28
- DOI
- https://doi.org/10.7189/jogh.15.04324
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00